Device brand name · Staple implantable
Egia Ultra Universal Stapler: medical device reports filed with FDA
422 reports name it, 2010–2017. Manufacturer given most often on reports: Covidien Formerly Ussc Puerto Rico. Product code GDW.
- 422
- device reports naming the brand
- 0% of all MAUDE reports · about 26 a year
- 0
- reports, 12 months to August 2026
- 0 in the 12 months before
- 5.7%
- classified as malfunction
- 80.3% across the product code
- 2.8%
- classified as death, as reported
- 12 reports · not verified by FDA
422 medical device reports received by FDA name the brand "Egia Ultra Universal Stapler" (staple implantable); the manufacturer given most often on reports is Covidien Formerly Ussc Puerto Rico; received from June 2010 to March 2017. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (91.2%), malfunction (5.7%) and death (2.8%); across all staple, implantable reports (product code GDW) death is recorded in 0.6% and malfunction in 80.3%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are failure to form staple (24.2%), difficult to open or close (17.1%) and failure to fire (12.6%). The patient problems coded most often are tissue damage, hemorrhage/blood loss/bleeding and injury. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
No report naming Egia Ultra Universal Stapler was received in the five years to August 2026; the latest was received in March 2017.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 170,752 reports carrying product code GDW. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Failure to form staple | 102 | 24.2% | 20.5% |
| Difficult to open or close | 72 | 17.1% | 9.7% |
| Failure to fire | 53 | 12.6% | 30% |
| Entrapment of device | 46 | 10.9% | 3.2% |
| Misfire | 46 | 10.9% | 9.1% |
| Noise, audible | 39 | 9.2% | 2.3% |
| Device operates differently than expectedthe device behaved unexpectedly | 35 | 8.3% | 2.3% |
| Difficult to removethe device was hard to remove | 32 | 7.6% | 1.7% |
| Mechanical jam | 23 | 5.5% | 2.3% |
| Mechanical problema mechanical problem | 18 | 4.3% | 1.1% |
| Retraction problem | 17 | 4% | 1.2% |
| Breakthe device broke | 16 | 3.8% | 4.9% |
| Insufficient device problem information | 15 | 3.6% | 2.9% |
| Sticking | 14 | 3.3% | 1.2% |
| Positioning failure | 12 | 2.8% | 1.1% |
| Detachment of device component | 8 | 1.9% | 1.2% |
| Failure to adhere or bond | 8 | 1.9% | 0.4% |
| Activation, positioning or separation problem | 7 | 1.7% | 0.2% |
| Failure to cycle | 7 | 1.7% | 0.2% |
| Device stops intermittentlythe device stopped now and then | 6 | 1.4% | 0.1% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Tissue damage | 152 | 36% |
| Hemorrhage/blood loss/bleeding | 86 | 20.4% |
| Injurya physical injury | 62 | 14.7% |
| Failure to anastomose | 45 | 10.7% |
| Blood loss | 38 | 9% |
| Deaththe patient died; cause not stated by this term | 12 | 2.8% |
| Device embedded in tissue or plaque | 5 | 1.2% |
| Fistula | 4 | 0.9% |
| Laceration(s) | 4 | 0.9% |
| Exsanguination | 3 | 0.7% |
| Painpain, site not specified | 3 | 0.7% |
| Perforation | 3 | 0.7% |
| Wound dehiscencea wound reopened | 3 | 0.7% |
| Abscessa collection of pus | 2 | 0.5% |
| Foreign body in patientpart of a device left in the patient | 2 | 0.5% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Egia Ultra Universal Stapler | Product code GDW | All MAUDE reports |
|---|---|---|---|
| Reports | 422 | 170,752 | 26,136,888 |
| Share of that pool | — | 0.2% | 0% |
| Classified as death, per 1,000 reports | 28 | 6 | 9 |
| Classified as injury | 91.2% | 18.7% | 36.2% |
| Classified as malfunction | 5.7% | 80.3% | 62.3% |
| Filed by the manufacturer | 99.5% | 97% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code GDW
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Endo GIA | 30,619 | 2,086 | 0.3% |
| Endo GIA Ultra | 17,281 | 1,116 | 0.1% |
| Signia | 9,434 | 1,130 | 0.1% |
| Tri-Staple 2.0 | 5,267 | 661 | 0.3% |
| Gia | 4,899 | 404 | 0.9% |
| Eea | 4,922 | 542 | 0.8% |
| Powered 60 Echelon + 340mm Shaft | 3,237 | 224 | 0.4% |
| Ets Flex Articng Lnr Cutr 45mm | 2,512 | 79 | 0.3% |
| Unknown Endo GIA SULU | 2,408 | 205 | 1.9% |
| SureForm | 2,927 | 654 | 1.2% |
| Contour Curved Cutter Stapler | 1,961 | 11 | 0.3% |
| Ils 29mm Curved | 1,945 | 48 | 0.9% |
| Powered 60 Echelon + 440mm Shaft | 1,775 | 49 | 0.4% |
| Echelon Flex Powered Vascular Stapler With Advanced Placement Tip | 1,770 | 180 | 1.6% |
| 75mm Selectable New Tlc | 1,603 | 57 | 1.1% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Egia Ultra Universal Stapler reports
How many FDA reports name Egia Ultra Universal Stapler?
422 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.
What kinds of events are reported?
injury (91.2%), malfunction (5.7%) and death (2.8%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
failure to form staple (24.2%), difficult to open or close (17.1%), failure to fire (12.6%), entrapment of device (10.9%) and misfire (10.9%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (99.5%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Egia Ultra Universal Stapler was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.